Nath Bio-Genes (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes has submitted a routine compliance certificate to the stock exchanges (BSE and NSE) for the quarter ended 30th June 2025, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate was issued by the company's Registrar and Share Transfer Agent, M/s Bigshare Services Pvt. Ltd. It confirms that all physical share certificates received for dematerialization were verified, mutilated, cancelled, and the depository's name was substituted in the register of members within the required 15-day timeline. The filing also confirms that securities received from depository participants were duly processed and listed on the stock exchanges.
This is a standard quarterly regulatory compliance filing with no material impact on the company's business, financials, or stock price. It simply confirms the RTA handled share dematerialization requests properly during the quarter.